Clearpoint Neuro
ClearPoint Neuro, Inc. Home Page - ClearPoint Neuro.
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 14 % | 27 % | 26 % | 17 % | 31 % | 22 % | 28 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (37 %) | (78 %) | (76 %) | (88 %) | (57 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (53 %) | (88 %) | (80 %) | (92 %) | (60 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 37 % | 55 % | 53 % | 49 % | 39 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
ClearPoint Neuro operates in the medical technology sector, specializing in neurosurgical solutions that integrate real-time direct imaging with advanced hardware and software. The company's core product enables neurosurgeons to make precise intraprocedural adjustments, enhancing the accuracy and efficacy of brain surgeries. ClearPoint Neuro serves a diverse client base, including healthcare professionals, biologics drug delivery partners, and researchers involved in gene and cell therapy, as well as clinical trials targeting the central nervous system (CNS). The company generates revenue through the sale of its specialized medical devices, software solutions, and collaborative research services. By partnering with over 60 global neurosurgery centers and participating in more than 4500 procedures, ClearPoint Neuro has established itself as a leader in the field. The company also collaborates with 30 partners in biologics drug delivery, further expanding its market reach. ClearPoint Neuro's business model focuses on providing cutting-edge technology that supports translational research and clinical applications, ensuring continuous innovation and improvement in neurosurgical practices.
Keywords: neurosurgery, real-time imaging, hardware, software, intraprocedural adjustments, CNS, gene therapy, cell therapy, clinical trials, medical technology.